These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2989389)

  • 21. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ; Pavone A; Rupp T; Cantu AR
    Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oromucosal interferon therapy: marked antiviral and antitumor activity.
    Tovey MG; Maury C
    J Interferon Cytokine Res; 1999 Feb; 19(2):145-55. PubMed ID: 10090400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of lambda-, beta-, and gamma-interferons in the presence of theophylline: involvement of 2',5'-oligo(A) synthetase.
    Krispin TI; Parfenova TM; Itkes AV; Balandin IG; Kuznetsov VP; Severin ES
    Biochem Int; 1984 Jan; 8(1):159-64. PubMed ID: 6089814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral effects of human fibroblast interferon from Escherichia coli against encephalomyocarditis virus infection of squirrel monkeys.
    Weck PK; Harkins RN; Stebbing N
    J Gen Virol; 1983 Feb; 64 (Pt 2)():415-9. PubMed ID: 6300291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
    Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
    Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of trehalose dimycolate-induced interferon-alpha/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures.
    Guillemard E; Geniteau-Legendre M; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
    Antiviral Res; 1995 Oct; 28(2):175-89. PubMed ID: 8585770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.
    Eppstein DA; Marsh YV; van der Pas M; Felgner PL; Schreiber AB
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3688-92. PubMed ID: 3159018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta.
    Oleszak E; Stewart WE
    J Interferon Res; 1985; 5(2):361-71. PubMed ID: 2989390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
    Fish EN; Banerjee K
    Prog Clin Biol Res; 1985; 202():385-90. PubMed ID: 3008171
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection.
    Minagawa H; Takenaka A; Mohri S; Mori R
    Antiviral Res; 1987 Sep; 8(2):85-95. PubMed ID: 2830846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.
    Stebbing N; Lindley IJ
    Arch Virol; 1980; 64(1):57-66. PubMed ID: 6246856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-specific effects of recombinant porcine interferon-gamma and the induction of Mx proteins in pig cells.
    Horisberger MA
    J Interferon Res; 1992 Dec; 12(6):439-44. PubMed ID: 1337754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human interferon-alpha-and-gamma-mediated inhibition of retrovirus production in the absence of an inhibitory effect on vesicular stomatitis virus and encephalomyocarditis virus replication in RD-114 cells.
    Herz RE; Rubin BY; Sen GC
    Virology; 1983 Feb; 125(1):246-50. PubMed ID: 6299008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral effects of bacteria-derived human leukocyte interferons against encephalomyocarditis virus infection of squirrel monkeys. Brief report.
    Stebbing N; Weck PK; Fenno JT; Estell DA; Rinderknecht E
    Arch Virol; 1983; 76(4):365-72. PubMed ID: 6312932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential antiproliferative effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines.
    Brunda MJ; Wright RB
    Int J Cancer; 1986 Feb; 37(2):287-91. PubMed ID: 3080378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections.
    Pinto AJ; Morahan PS; Brinton M; Stewart D; Gavin E
    J Interferon Res; 1990 Jun; 10(3):293-8. PubMed ID: 1696607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
    Tan H; Derrick J; Hong J; Sanda C; Grosse WM; Edenberg HJ; Taylor M; Seiwert S; Blatt LM
    J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.